TY - JOUR
T1 - Canadian cardiovascular society guidelines on the use of cardiac resynchronization therapy
T2 - Implementation
AU - Parkash, Ratika
AU - Philippon, François
AU - Shanks, Miriam
AU - Thibault, Bernard
AU - Cox, Jafna
AU - Low, Aaron
AU - Essebag, Vidal
AU - Bashir, Jamil
AU - Moe, Gordon
AU - Birnie, David H.
AU - Larose, Éric
AU - Yee, Raymond
AU - Swiggum, Elizabeth
AU - Kaul, Padma
AU - Redfearn, Damian
AU - Tang, Anthony S.
AU - Exner, Derek V.
PY - 2013/11
Y1 - 2013/11
N2 - Recent studies have provided the impetus to update the recommendations for cardiac resynchronization therapy (CRT). This article provides guidance on the implementation of CRT and is intended to serve as a framework for the implementation of CRT within the Canadian health care system and beyond. These guidelines were developed through a critical evaluation of the existing literature, and expert consensus. The panel unanimously adopted each recommendation. The 9 recommendations relate to patient selection in the presence of comorbidities, delivery and optimization of CRT, and resources required to deliver this therapy. The strength of evidence was weighed, taking full consideration of any risk of bias, and any imprecision, inconsistency, and indirectness of the available data. The strength of each recommendation and the quality of evidence were adjudicated. Trade-offs between desirable and undesirable consequences of alternative management strategies were considered, as were values, preferences, and resource availability. These guidelines were externally reviewed by experts, modified based on those reviews, and will be updated as new knowledge is acquired.
AB - Recent studies have provided the impetus to update the recommendations for cardiac resynchronization therapy (CRT). This article provides guidance on the implementation of CRT and is intended to serve as a framework for the implementation of CRT within the Canadian health care system and beyond. These guidelines were developed through a critical evaluation of the existing literature, and expert consensus. The panel unanimously adopted each recommendation. The 9 recommendations relate to patient selection in the presence of comorbidities, delivery and optimization of CRT, and resources required to deliver this therapy. The strength of evidence was weighed, taking full consideration of any risk of bias, and any imprecision, inconsistency, and indirectness of the available data. The strength of each recommendation and the quality of evidence were adjudicated. Trade-offs between desirable and undesirable consequences of alternative management strategies were considered, as were values, preferences, and resource availability. These guidelines were externally reviewed by experts, modified based on those reviews, and will be updated as new knowledge is acquired.
UR - http://www.scopus.com/inward/record.url?scp=84886845058&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84886845058&partnerID=8YFLogxK
U2 - 10.1016/j.cjca.2013.09.009
DO - 10.1016/j.cjca.2013.09.009
M3 - Article
C2 - 24182753
AN - SCOPUS:84886845058
SN - 0828-282X
VL - 29
SP - 1346
EP - 1360
JO - Canadian Journal of Cardiology
JF - Canadian Journal of Cardiology
IS - 11
ER -